FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely urology, andrology and endocrinology, and may be used for the integrated treatment of pathozoospermia in males suffering adrenal hyperandrogenism. For this purpose, dexamethasone 0.5 mg is administered additionally twice a day for 8 weeks with underlying standard regimen. Besides, the blood is UV-radiated 3 times a week for 15 minutes; the therapeutic course is 12 procedures.
EFFECT: method provides normalising spermatogenesis ensured by improved microcirculation, anti-inflammatory, immunopotentiating, antioxidant effects, as well as high repair activity with no side effects and substantial contraindications to the treatment.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INTEGRATED TREATMENT OF MALE NORMOGONADOTROPIC INFERTILITY | 2012 |
|
RU2480256C1 |
| APPLICATION OF MUSK DEER MUSK TINCTURE AND ULTRAVIOLET IRRADIATION OF BLOOD FOR TREATMENT OF SPERMATOGENIC FAILURE IN MEN OF REPRODUCTIVE AGE | 2010 |
|
RU2418581C1 |
| METHOD FOR FORECASTING EFFICIENCY OF LOW-INTENSITY LASER THERAPY IN SECRETORY ASTENOZOSPERMIA | 2020 |
|
RU2748895C1 |
| METHOD OF TREATING AUTOIMMUNE MALE STERILITY | 2010 |
|
RU2430725C1 |
| METHOD FOR TREATING AUTOIMMUNE MALE INFERTILITY CASES | 2005 |
|
RU2294779C1 |
| METHOD FOR TREATING THE CASES OF MALE ATOUIMMUNE INFERTILITY | 2000 |
|
RU2185211C2 |
| METHOD FOR PREDICTING SPERMATOGENESIS STIMULATION EFFECTIVENESS IN OLIGOSPERMIC INFERTILITY (SECRETORY OLYGO- AND AZOOSPERMIA) CASES | 2004 |
|
RU2302641C2 |
| METHOD FOR PREDICTION OF EFFICIENCY OF LOW-INTENSITY LASER THERAPY IN SECRETARY TERATOZOSPERMIA | 2021 |
|
RU2759539C1 |
| USE OF OXIDISED DEXTRAN FOR TREATING AND PREVENTING INFECTIOUS-INFLAMMATORY DISORDERS OF SPERMATOGENESIS | 2023 |
|
RU2814617C1 |
| METHOD FOR APPLYING CRYOPLSMASORPTION | 2003 |
|
RU2238110C1 |
